APP and Cognitive impairment: In APP/PS1 and BV2 models, environmentally relevant doses of PS-NPs exacerbate cognitive deficits and Aβ-plaque deposition by disrupting lysosomal function and inducing microglial pyroptosis, reducing their phagocytic capacity.